VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

SOHO 2020 | Point-of-care CAR T-cells

Marcos de Lima • 16 Sep 2020
SOHO 2020
General CAR-T
Immuno-Oncology Treatment

Marcos de Lima, MD, UH Cleveland Medical Center, Cleveland, OH, discusses the significance of point-of-care CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Marcos de Lima

3:40
Results of a site-manufactured anti-CD19 CAR-T in nHL
Marcos de Lima • 24 Aug 2020
5:18
Outlook on the current CAR-T climate
Marcos de Lima • 24 Aug 2020

Related Videos

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
The content of VJRegenMed is intended for healthcare professionals